Intermediate AMD Market is driven by Rising Prevalence of Disease

adicionou um novo artigo Wellness

2025-06-17 07:17:31 -

The Intermediate Age-Related Macular Degeneration (AMD) Market encompasses diagnostic tools, pharmaceutical therapies, and novel biologics designed to slow disease progression between early and late stages of AMD. Key products include complement inhibitors, injectable anti-VEGF agents, and sustained-release implants that deliver targeted treatment directly to the retina. These therapies offer...

0 Comentários 0 Compartilhamentos 130 Visualizações 0 Anterior